Literature DB >> 132078

Morphological and biochemical studies of a case of mucopolysaccharidosis II (Hunter's syndrome).

K Nagashima, H Endo, K Sakakibara, Y Konishi, K Miyachi, J J Wey, Y Suzuki, J Onisawa.   

Abstract

An autopsy case of a 19-year-old boy who had shown typical gargoyle features, strictly consistent with mucopolysaccharidosis type II (Hunter's syndrome) was reported. Histologically, cytoplasmic vacuolar change was found in hepatocytes, sinusoidal epithelium of spleen, follicular cells of thyroid, Sertoli cells of testis, chromophobe cell of pituitary and generalized fibroblast-like cells including meninges, cardiac valve and periosteum. The vacuoles consisting of membrane-bound structures with flocculus protein-like material and occasional electron dense bodies on electron microscopy, were considered to be the site of mucopolysaccharide deposition by histochemical analysis. Deposition of lipid material consistent with so-called membranous cytoplasmic body was observed in the neurons of central, peripheral and autonomic nervous system. Hepatosplenomegaly could be explained by cytoplasmic deposition, but the cause of cardiomegaly remained further to be studied. Biochemically hepatic mucopolysaccharide was identified as heparan sulfate, while in the kidney dermatan sulfate and heparan sulfate were detected. The correlation between morphology and biochemistry, and between deposition and degeneration was discussed.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 132078     DOI: 10.1111/j.1440-1827.1976.tb03297.x

Source DB:  PubMed          Journal:  Acta Pathol Jpn        ISSN: 0001-6632


  9 in total

1.  Laronidase replacement therapy and left ventricular function in mucopolysaccharidosis I.

Authors:  Haruhito Harada; Hiroshi Niiyama; Atsushi Katoh; Hisao Ikeda
Journal:  JIMD Rep       Date:  2014-05-22

2.  Growth patterns and the use of growth hormone in the mucopolysaccharidoses.

Authors:  L E Polgreen; B S Miller
Journal:  J Pediatr Rehabil Med       Date:  2010

3.  Growth, final height and endocrine sequelae in a UK population of patients with Hurler syndrome (MPS1H).

Authors:  Chris J Gardner; Nicola Robinson; Tim Meadows; Robert Wynn; Andrew Will; Jean Mercer; Heather J Church; Karen Tylee; J Edmond Wraith; Peter E Clayton
Journal:  J Inherit Metab Dis       Date:  2011-01-21       Impact factor: 4.982

4.  MRI findings in the mild type of mucopolysaccharidosis II (Hunter's syndrome).

Authors:  S Shimoda-Matsubayashi; Y Kuru; H Sumie; T Ito; N Hattori; Y Okuma; Y Mizuno
Journal:  Neuroradiology       Date:  1990       Impact factor: 2.804

5.  Effect of recombinant human growth hormone on changes in height, bone mineral density, and body composition over 1-2 years in children with Hurler or Hunter syndrome.

Authors:  Lynda E Polgreen; William Thomas; Paul J Orchard; Chester B Whitley; Bradley S Miller
Journal:  Mol Genet Metab       Date:  2013-12-11       Impact factor: 4.797

6.  Analysis of male reproductive parameters in a murine model of mucopolysaccharidosis type I (MPS I).

Authors:  Cinthia Castro do Nascimento; Odair Aguiar Junior; Vânia D'Almeida
Journal:  Int J Clin Exp Pathol       Date:  2014-05-15

7.  Myelin and Lipid Composition of the Corpus Callosum in Mucopolysaccharidosis Type I Mice.

Authors:  Steven Q Le; Igor Nestrasil; Shih-Hsin Kan; Martin Egeland; Jonathan D Cooper; David Elashoff; Rong Guo; Jakub Tolar; Jennifer K Yee; Patricia I Dickson
Journal:  Lipids       Date:  2020-06-14       Impact factor: 1.880

8.  Anterior Hypopituitarism and Treatment Response in Hunter Syndrome: A Comparison of Two Patients.

Authors:  Munier A Nour; Paola Luca; David Stephure; Xing-Chang Wei; Aneal Khan
Journal:  Case Rep Pediatr       Date:  2016-11-28

9.  A deletion of IDUA exon 10 in a family of Golden Retriever dogs with an attenuated form of mucopolysaccharidosis type I.

Authors:  Kiterie M E Faller; Alison E Ridyard; Rodrigo Gutierrez-Quintana; Angie Rupp; Celia Kun-Rodrigues; Tatiana Orme; Karen L Tylee; Heather J Church; Rita Guerreiro; Jose Bras
Journal:  J Vet Intern Med       Date:  2020-08-12       Impact factor: 3.333

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.